Do Fish Oils Prevent Restenosis Post-Coronary Angioplasty?
NCT00000473 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2013-12-13
Summary
To determine whether a dietary supplement of n-3 polyunsaturated fatty acids (PUFAs) derived from fish oil would decrease the restenosis rate in patients undergoing percutaneous transluminal coronary angioplasty (PTCA).
Conditions
- Cardiovascular Diseases
- Coronary Disease
- Heart Diseases
- Myocardial Ischemia
Interventions
- BEHAVIORAL
-
dietary supplements
- DRUG
-
fatty acids, omega-3
- BEHAVIORAL
-
diet, fat-restricted
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Alexander Leaf · Massachusetts General Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1989-07-31
- Completion
- 1994-06-30
More Related Trials
-
Fish Oil and Biomarkers of Cardiovascular Risk
NCT00527436 ·Status: TERMINATED ·Phase: NA
-
Fish Oil-derived N-3 Polyunsaturated Fatty Acids and Extracellular Vesicles
NCT03203512 ·Status: COMPLETED ·Phase: NA
-
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
NCT01624727 ·Status: COMPLETED ·Phase: NA
-
Cardiometabolic Benefits of Omega-3 Polyunsaturated Fatty Acids
NCT03378232 ·Status: COMPLETED ·Phase: NA
-
Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging
NCT00729430 ·Status: COMPLETED ·Phase: PHASE3
-
Omega 3 Fatty Acid Efficiency for Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting
NCT01175330 ·Status: TERMINATED ·Phase: PHASE3
-
Omega 3 Fatty Acids and Atrial Fibrillation
NCT00508248 ·Status: WITHDRAWN ·Phase: NA
-
A Study of Different Types of Fatty Acid on Risk Factors for Heart Disease
NCT01351324 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids, the Omega-3 Index, and Atherosclerosis
NCT00886704 ·Status: COMPLETED ·Phase: NA
-
Omega 3 Action on Cardiovascular Risk Factors in Patients Treated With Statins
NCT00976872 ·Status: COMPLETED ·Phase: NA
-
Effects of High-dose n-3 Fatty Acids on Clinical Outcome and Serum Lipids - Omacor Following Acute Myocardial Infarction
NCT01422317 ·Status: COMPLETED ·Phase: PHASE3
-
Omega-3 Fatty Acids in Elderly Patients With Acute Myocardial Infarction
NCT01841944 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Effects of Omega-3 Fatty Acids on Heart Disease and Behavior
NCT00663871 ·Status: COMPLETED ·Phase: NA
-
Intervention With Omega Fatty Acids in High-risk Patients
NCT02647333 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Omega 3 Fatty Acids on Vascular Function
NCT01888211 ·Status: COMPLETED ·Phase: NA
-
Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy
NCT01690312 ·Status: COMPLETED ·Phase: NA
-
The ALA, DHA and EPA Esters in the Prevention of Cardiovascular Diseases.
NCT04743050 ·Status: UNKNOWN ·Phase: PHASE3
-
Fish Oil and Cardiovascular Suboptimal Health
NCT02103517 ·Status: COMPLETED ·Phase: PHASE3
-
Impacts of Omega-3-PUFA Enriched Chicken-meat and Eggs in Healthy Humans
NCT04127409 ·Status: COMPLETED ·Phase: NA
-
The Use of Fish Oil to Reduce Inflammation Caused by a Peripheral Vascular Intervention
NCT02096757 ·Status: COMPLETED ·Phase: NA
-
N-3 Polyunsaturated Fatty Acids Enriched Chicken Meet and Cardiovascular Function
NCT05725486 ·Status: UNKNOWN ·Phase: NA
-
Minimum Time Effect of Fish Oil on Arterial Stiffness
NCT06981364 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Docosapentaenoic Acid on Lipids and Other Risk Factors for Cardiovascular Disease
NCT04088240 ·Status: TERMINATED ·Phase: NA
-
Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers
NCT00682318 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Does Omega-3 Polyunsaturated Fatty Acids (PUFAs) Pretreatment Improve Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI)?
NCT01723345 ·Status: UNKNOWN ·Phase: PHASE3